MedTrace Logo

Iraq- Afghanistan War Lung Injury Using 19F MRI (DIAL1001006)

NCT03237364 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2020-03-10

No results posted yet for this study

Summary

The goal of this study is to evaluate the utilization of conventional 'thermally' polarized perfluorinated gases mixed with oxygen as an exogenous inert contrast agent to image the airway spaces in subjects with suspected lung disease, post deployment in Iraq and Afghanistan. This is an open label proof of concept study expanding on work here at Duke.

Conditions

  • Constrictive Bronchiolitis
  • Iraq-Afganistan War Lung Injury Syndrome

Interventions

DIAGNOSTIC_TEST

Perfluorinated Gas/Oxygen Mixture

19-Fluorine (19F) MRI of the lungs with 21%/79% Oxygen/Perfluorinated Gas, ≤ 25 liters, gas, single visit, \< 1 hour

Sponsors & Collaborators

  • Hal C Charles

    lead OTHER

Principal Investigators

  • Cecil Charles, PhD · Duke University Medical Center, Department of Radiology

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-19
Primary Completion
2019-03-01
Completion
2020-02-28
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03237364 on ClinicalTrials.gov